Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Aquaporin-1 regulates platelet procoagulant membrane dynamics and in vivo thrombosis
Ejaife O. Agbani, Christopher M. Williams, Yong Li, Marion T.J. van den Bosch, Samantha F. Moore, Adele Mauroux, Lorna Hodgson, Alan S. Verkman, Ingeborg Hers, Alastair W. Poole
Ejaife O. Agbani, Christopher M. Williams, Yong Li, Marion T.J. van den Bosch, Samantha F. Moore, Adele Mauroux, Lorna Hodgson, Alan S. Verkman, Ingeborg Hers, Alastair W. Poole
View: Text | PDF
Research Article Cell biology Hematology

Aquaporin-1 regulates platelet procoagulant membrane dynamics and in vivo thrombosis

  • Text
  • PDF
Abstract

In response to collagen stimulation, platelets use a coordinated system of fluid entry to undergo membrane ballooning, procoagulant spreading, and microvesiculation. We hypothesized that water entry was mediated by the water channel aquaporin-1 (AQP1) and aimed to determine its role in the platelet procoagulant response and thrombosis. We established that human and mouse platelets express AQP1 and localize to internal tubular membrane structures. However, deletion of AQP1 had minimal effects on collagen-induced platelet granule secretion, aggregation, or membrane ballooning. Conversely, procoagulant spreading, microvesiculation, phosphatidylserine exposure, and clot formation time were significantly diminished. Furthermore, in vivo thrombus formation after FeCl3 injury to carotid arteries was also markedly suppressed in AQP1-null mice, but hemostasis after tail bleeding remained normal. The mechanism involves an AQP1-mediated rapid membrane stretching during procoagulant spreading but not ballooning, leading to calcium entry through mechanosensitive cation channels and a full procoagulant response. We conclude that AQP1 is a major regulator of the platelet procoagulant response, able to modulate coagulation after injury or pathologic stimuli without affecting other platelet functional responses or normal hemostasis. Clinically effective AQP1 inhibitors may therefore represent a novel class of antiprocoagulant antithrombotics.

Authors

Ejaife O. Agbani, Christopher M. Williams, Yong Li, Marion T.J. van den Bosch, Samantha F. Moore, Adele Mauroux, Lorna Hodgson, Alan S. Verkman, Ingeborg Hers, Alastair W. Poole

×

Figure 4

Constitutive (whole animal) ablation of AQP1 suppresses thrombus formation in vivo and in vitro without affecting hemostasis.

Options: View larger image (or click on image) Download as PowerPoint
Constitutive (whole animal) ablation of AQP1 suppresses thrombus formati...
(A–C) Mice were administered DyLight 488–conjugated anti-GPIbβ antibody to label platelets. Carotid artery damage was achieved by treatment with FeCl3. Fluorescently labeled platelets were imaged by intravital microscopy. Images at frames indicated in A correspond to time points indicated in C. Wild-type (AQP1+/+) and AQP1-null (AQP1–/–) mice images show comparable growth rates and gross morphology. (B) Median fluorescence integrated density (MFID) is shown as interleaved box-and-whisker plots, with whiskers showing minimum to maximum values, medians, and interquartile ranges. (C) The time course of change in MFID (median and minimum and maximum values) for thrombus formation in AQP1+/+ and AQP1–/– mice. (D) Tail bleed times were assessed, and data shown are mean ± SEM of time to stop bleeding. (E) Ablation of AQP1 in platelets delayed clotting times in intrinsic pathway analyses of whole mouse blood coagulation. The inset shows thromboelastometry (ROTEM) data; the histogram shows clotting time (CT) and clot formation time (CFT) for freshly drawn, citrated whole AQP1+/+ and AQP1–/– mouse blood. Using a platelet-rich plasma (PRP) swap approach, blood is reconstituted as shown. AQP1P+/R+ indicates AQP1+/+ PRP combined with AQP1+/+ red and other cells (RBC); AQP1P+/R– indicates AQP1+/+ PRP combined with AQP1–/– RBC; AQP1P–/R+ indicates AQP1–/– PRP combined with AQP1+/+ RBC; and AQP1P–/R– indicates AQP1–/– PRP combined with AQP1–/– RBC. Data analysis was performed by Wilcoxon signed-rank test. Scale bar: 2 mm. *P < 0.05 was considered significant. Data were from 8 independent experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts